Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-01-26
DOI
10.1038/srep08029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth
- (2014) Isabel D. Alves et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer
- (2014) Bo Fu et al. BIOTECHNOLOGY LETTERS
- Mitochondrial dynamics: biology and therapy in lung cancer
- (2014) Frances E Lennon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting mitochondria in pancreatic cancer
- (2014) Alessia Errico Nature Reviews Clinical Oncology
- Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
- (2014) Samad Mussa Farkhani et al. PEPTIDES
- Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
- (2014) Carsten Nieder et al. Radiation Oncology
- A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
- (2013) Pia Bükmann Larsen et al. CANCER TREATMENT REVIEWS
- Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline
- (2013) M. J. Gil-Gil et al. Clinical & Translational Oncology
- Targeted Therapies in Brain Metastases
- (2013) Nancy U. Lin Current Treatment Options in Neurology
- Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide
- (2013) Ke Li et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting mitochondria: Strategies, innovations and challenges
- (2013) Marvin Edeas et al. MITOCHONDRION
- Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein
- (2013) Tao Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Progress in the Biological Understanding and Management of Breast Cancer-Associated Central Nervous System Metastases
- (2013) S. Dawood et al. ONCOLOGIST
- Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
- (2013) M. Cieslewicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual-Targeting Pro-apoptotic Peptide for Programmed Cancer Cell Death via Specific Mitochondria Damage
- (2013) Wei-Hai Chen et al. Scientific Reports
- Targeted Cell Uptake of a Noninternalizing Antibody Through Conjugation to Iron Oxide Nanoparticles in Primary Central Nervous System Lymphoma
- (2013) Tingzhong Wang et al. World Neurosurgery
- Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
- (2012) A. Jo Chien et al. BREAST CANCER RESEARCH AND TREATMENT
- Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis
- (2012) Fang Nie et al. CANCER
- Targeting cancer cell mitochondria as a therapeutic approach
- (2012) Shijun Wen et al. Future Medicinal Chemistry
- Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD
- (2012) Ronghua Liu et al. JOURNAL OF CONTROLLED RELEASE
- In Vivo Near-Infrared Imaging of Fibrin Deposition in Thromboembolic Stroke in Mice
- (2012) Yi Zhang et al. PLoS One
- Anti-Tumor Effects of the Peptide TMTP1-GG-D(KLAKLAK)2 on Highly Metastatic Cancers
- (2012) Xiangyi Ma et al. PLoS One
- The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH
- (2011) Hyo Young Kim et al. BIOMATERIALS
- The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models
- (2011) Hong Zhao et al. BREAST CANCER RESEARCH AND TREATMENT
- A Novel Peptide Probe for Imaging and Targeted Delivery of Liposomal Doxorubicin to Lung Tumor
- (2011) Xiaofeng He et al. MOLECULAR PHARMACEUTICS
- Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide
- (2011) S. Hatakeyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TAT Fusion Protein Transduction into Isolated Mitochondria Is Accelerated by Sodium Channel Inhibitors
- (2010) Jayanagendra P. Rayapureddi et al. BIOCHEMISTRY
- Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
- (2010) Kathlynn Brown CURRENT PHARMACEUTICAL DESIGN
- Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting Peptides
- (2010) Hao Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of metastasis
- (2008) Georg F. Weber CANCER LETTERS
- Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
- (2008) B. Gril et al. JNCI-Journal of the National Cancer Institute
- Antitumor effect of a transducible fusogenic peptide releasing multiple proapoptotic peptides by caspase-3
- (2008) Mi-Kyung Kwon et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started